Abstract

Research Article

The validity of progesterone level on hCG injection day in the prediction of IVF/ICSI cycles’ outcome

Mostafa A Abolfotouh*, Hallah Al-Anazi and Samar Hassan

Published: 11 September, 2019 | Volume 2 - Issue 2 | Pages: 095-100

Background: Previous studies highlighted the negative effect of premature progesterone elevation (PE) during IVF cycles on the cycle outcomes. The aim of this study was to assess the validity of progesterone level on hCG day (P4) in the prediction of IVF/ICSI cycles’ outcome.

Methods: In a retrospective cohort study, all fresh cycles of 256 patients who underwent IVF or ICSI cycles in 2017 at reproductive endocrinology & infertility unit/ Obg/Gyn department at King Abdulaziz Medical city, Riyadh, Saudi Arabia, were followed up. They were started on gonadotropin medications for ovarian hyperstimulation, followed by serial transvaginal U/S and serum estrogen levels each visit. Patients having 2 or more 18mm follicles were triggered by hCG 10,000 IU and ovum pickup was done 34-36 hrs after. Data were collected on patients’ characteristics [age, BMI infertility type], cycles’ characteristics [number of follicles and endometrium thickness on hCG day, P4 and estrogen levels], rates of pregnancy and pregnancy outcomes. Receiver operating characteristic curve was applied to determine the cut-off of P4 that corresponds with a negative pregnancy test. Logistic regression analysis was used and significance was considered at p - value of ≤0.05.

Results: Pregnancy rate in the study sample was 36.7%. The mean P4 level in cycles with negative pregnancy tests was significantly higher than the mean in cycles with positive tests (p = 0.018). After adjusting for confounders, significant negative association between P4 and pregnancy rate was evident (p < 0.03). The optimum trade-off of P4 for prediction of a negative pregnancy test was 1.5nmol/L. This cut-off level had a 59% sensitivity, 51% specificity and 68% positive predictive value and 10% & 15% absolute and relative risk reductions respectively. Cycles with mean P4 of ≥1.5nmol/L were significantly associated with primary infertility (p = 0.011), lower mean BMI (p = 0.009) higher mean estrogen level (p < 0.001), lower live birth rate (p = 0.048), higher abortion rate (p = 0.039), and higher ovarian hyperstimulation rate (p = 0.027).

Conclusion: Premature elevation of progesterone level on the hCG day in IVF/ICSI cycles may have adversely impacted the pregnancy rate and pregnancy outcome. The cutoff point of 1.5nmol/L for this P4 was not valid in predicting pregnancy outcomes. 

Read Full Article HTML DOI: 10.29328/journal.cjog.1001028 Cite this Article Read Full Article PDF

Keywords:

Pregnancy rate; Premature progesterone rise; Prediction: Validity; Ovarian hyper stimulation; Pregnancy outcome

References

  1. Hugues JN, Massé-Laroche E, Reboul-Marty J, Boîko O, Meynant C, et al. Impact of endogenous luteinizing hormone serum levels on progesterone elevation on the day of human chorionic gonadotropin administration. Fertil Steril. 2011; 96: 600-604. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21880277
  2. Del Castillo JL, Bousamra M, De La Fuente L, Ruiz-Balda JA, Palomo M. The impact of serum progesterone levels on the results of in vitro fertilization treatments: a literature review. JBRA Assist Reprod. 2015; 19: 141-147. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/27203093
  3. Edelstein MC, Seltman HJ, Cox BJ, Robinson SM, Shaw RA, et al. Progesterone levels on the day of human chorionic gonadotropin administration in cycles with gonadotropin-releasing hormone agonist suppression are not predictive of pregnancy outcome. Fertil Steril. 1990; 54: 853-857. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/2121554
  4. Silverberg KM, Burns WN, Olive Dl, Riehl RM, Schenken RS. Serum progesterone levels predict success of in vitro fertilization/embryo transfer in patients stimulated with leuprolide acetate and human menopausal gonadotropins. J Clin Endocrinol Metab. 1991; 73: 797-803. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/1909704
  5. Bosch E, Valencia I, Escudero E, Crespo J, Simón C, et al. Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome. Fertil Steril. 2003; 80: 1444-1449. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/14667881
  6. Ubaldi F, Albano C, Peukert M, Riethmüller-Winzen H, Camus M, et al. Endocrinology: subtle progesterone rise after the administration of the gonadotrophin-releasing hormone antagonist Cetrorelix in intracytoplasmic sperm injection cycles. Hum Reprod. 1996; 11: 1405-1407. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/8671476
  7. Bosch E, Labarta E, Crespo J, Simon C, Remohi J, et al. Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles. Human reproduction. 2010; 25: 2092-2100. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/20539042
  8. Al-Azemi M, Kyrou D, Kolibianakis EM, Humaidan P, Van Vaerenbergh I, et al. Elevated progesterone during ovarian stimulation for IVF. Reprod Biomed Online. 2012; 24: 381-388. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22377153
  9. Venetis CA, Kolibianakis EM, Bosdou JK, Tarlatzis BC. Progesterone elevation and probability of pregnancy after IVF: a systematic review and meta-analysis of over 60 000 cycles. Hum Reprod Update. 2013; 19: 433-457. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23827986
  10. Labarta E, Martínez-Conejero JA, Alamá P, Horcajadas JA, Pellicer A, et al. Endometrial receptivity is affected in women with high circulating progesterone levels at the end of the follicular phase: a functional genomics analysis. Hum Reprod. 2011; 26: 1813-1825. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21540246
  11. Li R, Qiao J, Wang L, Li L, Zhen X, et al. MicroRNA array and microarray evaluation of endometrial receptivity in patients with high serum progesterone levels on the day of hCG administration. Reprod Biol Endocrinol. 2011; 9: 29. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21375772
  12. Haouzi D, Bissonnette L, Gala A, Assou S, Entezami F, et al. Endometrial receptivity profile in patients with premature progesterone elevation on the day of HCG administration. BioMed Res Int. 2014; 2014. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022194/
  13. Schoolcraft W, Sinton E, Schlenker T, Huynh D, Hamilton F, et al. Lower pregnancy rate with premature luteinization during pituitary suppression with leuprolide acetate. Fertil Steril. 1991; 55: 563-566. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/1900481
  14. Xu B, Li Z, Zhang H, Jin L, Li Y, et al. Serum progesterone level effects on the outcome of in vitro fertilization in patients with different ovarian response: an analysis of more than 10,000 cycles. Fertil Steril. 2012; 97: 1321-1327. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22494924
  15. Papanikolaou EG, Pados G, Grimbizis G, Bili E, Kyriazi L, et al. GnRH-agonist versus GnRH-antagonist IVF cycles: is the reproductive outcome affected by the incidence of progesterone elevation on the day of HCG triggering? A randomized prospective study. Hum Reprod. 2012; 27: 1822-1828. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22422777
  16. Ochsenkühn R, Arzberger A, von Schönfeldt V, Gallwas J, Rogenhofer N, et al. Subtle progesterone rise on the day of human chorionic gonadotropin administration is associated with lower live birth rates in women undergoing assisted reproductive technology: a retrospective study with 2,555 fresh embryo transfers. Fertil Steril. 2012; 98: 347-354. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22633265
  17. Huang CC, Lien YR, Chen HF, Chen MJ, Shieh CJ, et al. The duration of pre-ovulatory serum progesterone elevation before hCG administration affects the outcome of IVF/ICSI cycles. Hum Reprod. 2012; 27: 2036-2045. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22561057
  18. Huang PC, Chen MJ, Guu HF, Yi YC, Ho JY, et al. Effect of premature serum progesterone rise on embryo transfer outcomes and the role of blastocyst culture and transfer in assisted reproductive technology cycles with premature progesterone rise. Taiwan J Obstet Gynecol. 2015; 54: 641-646. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/26700978
  19. Ashmita J, Vikas S, Swati G. The impact of progesterone level on day of hCG injection in IVF Cycles on clinical pregnancy rate. J Hum Reprod Sci. 2017; 10: 265-270. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29430153
  20. Mascarenhas M, Kamath MS, Chandy A, Kunjummen AT. Progesterone/estradiol ratio as a predictor in the ART cycles with premature progesterone elevation on the day of hCG trigger. J Reprod Infertil. 2015; 16: 155-161. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/26913234
  21. Elnashar AM. Progesterone rise on the day of HCG administration (premature luteinization) in IVF: an overdue update. J Assist Reprod Genet. 2010; 27: 149-155. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/20177771
  22. Papanikolaou EG, Kolibianakis EM, Pozzobon C, Tank P, Tournaye H, et al. Progesterone rise on the day of human chorionic gonadotropin administration impairs pregnancy outcome in day 3 single-embryo transfer, while has no effect on day 5 single blastocyst transfer. Fertil Steril. 2009; 91: 949-952. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17555751
  23. Andersen AN, Devroey P, Arce JC. Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial. Human Reproduction. 2006; 21: 3217-3227. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/16873892
  24. Kiliçdag EB, Haydardedeoglu B, Cok T, Hacivelioglu SO, Bagis T. Premature progesterone elevation impairs implantation and live birth rates in GnRH-agonist IVF/ICSI cycles. Arch Gynecol Obstet. 2010; 281: 747-752. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/19862542
  25. Kyrou D, Al-Azemi M, Papanikolaou EG, Donoso P, Tziomalos K, et al. The relationship of premature progesterone rise with serum estradiol levels and number of follicles in GnRH antagonist/recombinant FSH-stimulated cycles. Eur J Obstet Gynecol Reprod Biol. 2012; 162: 165-168. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22425288

Figures:

Figure 1

Figure 1

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More